NMN (β-Nicotinamide Mononucleotide)
NMN (Beta-Nicotinamide Mononucleotide) is a naturally occurring nucleotide found in trace amounts in edamame, broccoli, and avocado that serves as a direct precursor to NAD+, the coenzyme essential for cellular energy production and DNA repair — making it one of the most significant longevity-focused nutrients for women over 35. In element³ RISE (AM Formula), NMN is dosed at 250mg to support mitochondrial function, mental stamina, and healthy ageing at the cellular level. If your energy has been declining year on year despite no change in lifestyle, your NAD+ levels may be part of the story.
[ 01 ] Key Facts
| Dose in element³ | 250mg |
|---|---|
| Form | β-Nicotinamide Mononucleotide (NMN) — direct NAD+ precursor |
| Signs you may need more | Persistent fatigue despite adequate sleep, slow recovery from exercise or illness, declining skin elasticity, poor concentration |
| Safe range | 125–500mg daily. Well-tolerated in human studies up to 1,200mg/day. Long-term safety data (>12 months) still emerging. |
Food sources
- Broccoli
- Cabbage
- Avocado
[ 02 ] Rationale
Why this ingredient is in element³
[ 03 ] At 35+
Relevant at 35+
[ 04 ] Your Questions
Your Questions
What is NMN?
What are the benefits of taking NMN?
What are the benefits of NMN in the element³ protocol?
What is the recommended daily intake of NMN?
What food provides NMN?
Are there any NMN side effects?
What are NMN deficiency symptoms?
What form of NMN is in the element³ blend?
What is NMN and what does it do?
What is the difference between NMN and NR?
NMN vs NAD+ supplements — which is better?
[ 05 ] The Research
The Research
| Study | Key finding | Why it's here | Read |
|---|---|---|---|
| Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older menIgarashi, M., Nakagawa-Nagahama, Y., Miura, M., Kashiwabara, K., Yaku, K., Sawada, M., Sekine, R., Fukamizu, Y., Sato, T., Sakurai, T., Sato, J., Ino, K., Kubota, N., Nakagawa, T., Kadowaki, T., & Yamauchi, T. (2022). Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Aging, 8(1), 5. https://doi.org/10.1038/s41514-022-00084-z | 12 weeks of NMN significantly increased whole-blood NAD+ and improved measures of muscular function (gait, grip) in healthy older men. |
Supports cellular NAD+ levels and mitochondrial function. |
Read → |
| Clinical evaluation of changes in biomarkers by oral intake of NMNMorita, Y., Izawa, H., Hirano, A., Mayumi, E., & Iwakawa, S. (2022). Clinical evaluation of changes in biomarkers by oral intake of NMN. Glycative Stress Research, 9(2), 33–41. | Eight weeks of oral NMN modulated biomarkers of NAD+ metabolism and oxidative stress in healthy adults. |
Supports NAD+ metabolism and cellular resilience. |
Read → |
| Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trialKatayoshi, T., Uehata, S., Nakashima, N., Nakajo, T., Kitajima, N., Kageyama, M., & Tsuji-Naito, K. (2023). Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: A randomized, double-blind, placebo-controlled trial. Scientific Reports, 13(1), 2786. https://doi.org/10.1038/s41598-023-29787-3 | Long-term NMN supplementation increased blood NAD+ and was associated with reduced arterial stiffness in middle-aged adults. |
Supports vascular health and cellular energy. |
Read → |
| The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trialYi, L., Maier, A. B., Tao, R., Lin, Z., Vaidya, A., Pendse, S., Thasma, S., Andhalkar, N., Avhad, G., & Kumbhar, V. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: A randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience, 45(1), 29–43. https://doi.org/10.1007/s11357-022-00705-1 | 60 days of NMN dose-dependently raised blood NAD+ and improved performance on a six-minute walk test and SF-36 physical scores in healthy middle-aged adults. |
Supports physical performance and cellular energy with healthy aging. |
Read → |
| The Safety and Antiaging Effects of Nicotinamide Mononucleotide in Human Clinical Trials: an UpdateSong, Q., Zhou, X., Xu, K., Liu, S., Zhu, X., & Yang, J. (2023). The safety and antiaging effects of nicotinamide mononucleotide in human clinical trials: An update. Advances in Nutrition, 14(6), 1416–1435. https://doi.org/10.1016/j.advnut.2023.08.008 | Updated systematic review of human NMN trials reporting consistent increases in NAD+ and benefits across aerobic capacity, sleep and cardiometabolic markers. |
Supports NAD+ replenishment and healthy aging. |
Read → |
[ 06 ] In the Protocol
